Literature DB >> 27307552

Cardiac Remodeling in Patients With Primary and Secondary Aldosteronism: A Tissue Doppler Study.

Maurizio Cesari1, Claudio Letizia1, Paolo Angeli1, Susanna Sciomer1, Silvia Rosi1, Gian Paolo Rossi2.   

Abstract

BACKGROUND: Primary aldosteronism (PA) causes excess left ventricular (LV) hypertrophy and diastolic dysfunction; whether this occurs also in secondary aldosteronism (SA) without hypertension is unknown. We investigated the cardiac modifications in patients with preserved LV ejection fraction who had PA or SA. METHODS AND
RESULTS: We measured several Doppler echocardiography-derived variables, including tissue Doppler imaging (TDI) parameters and strain rate analysis, in 262 patients with PA, 117 with SA because of liver cirrhosis, and in 61 control healthy subjects. SA and PA patients showed markedly elevated aldosterone levels (67 versus 39 ng/dL, respectively; normal values <15 ng/dL) but contrasting values of plasma renin activity (15.00 versus 0.56 ng/mL/h; P<0.001). Compared with PA, SA patients showed higher heart rate, and lower blood pressure and vascular resistance values. Both PA and SA showed increased LV diameters, LV volumes, stroke volume, stroke work, and septal peak systolic tissue velocity, and had more LV hypertrophy (61% and 39%, respectively) and diastolic dysfunction (35% and 36%, respectively) than healthy subjects. Peak systolic septal strain (20% versus 23%; P=<0.001) and midwall fractional shortening (15.9% versus 16.7%; P=0.001) were lower in PA than in SA patients.
CONCLUSIONS: Primary and secondary hyperaldosteronism correlate with LV enlargement and high prevalence of LV hypertrophy and diastolic dysfunction; a subclinical systolic dysfunction is evident only in PA. In SA, the high rate of LV hypertrophy, in spite of low peripheral resistances and low-to-normal blood pressure, could be accounted for the high renin and aldosterone values, and the work overload associated with a hyperdynamic circulatory state.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  aldosterone; cirrhosis; diastolic dysfunction echocardiography; echocardiography; hypertrophy; left ventricular systolic function; strain rate imaging

Mesh:

Substances:

Year:  2016        PMID: 27307552     DOI: 10.1161/CIRCIMAGING.116.004815

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  11 in total

Review 1.  Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.

Authors:  Teresa M Seccia; Brasilina Caroccia; Gail K Adler; Giuseppe Maiolino; Maurizio Cesari; Gian Paolo Rossi
Journal:  Hypertension       Date:  2017-04       Impact factor: 10.190

Review 2.  Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment.

Authors:  Gregory L Hundemer
Journal:  Curr Cardiol Rep       Date:  2019-07-27       Impact factor: 2.931

3.  Curable congestive heart failure in patients with primary aldosteronism: two cases reports.

Authors:  Zijun Chen; Zhe Zhang; Qianlan Xi; Guimei Huang; Liya Wang
Journal:  Am J Transl Res       Date:  2022-04-15       Impact factor: 4.060

4.  Diagnosis and Management of Cirrhotic Cardiomyopathy.

Authors:  Harpreet Kaur; Madhumita Premkumar
Journal:  J Clin Exp Hepatol       Date:  2021-08-21

5.  Aldosterone and renin in cardiac patients referred for catheterization.

Authors:  Paul Erne; Andrea Müller; Gian Paolo Rossi; Burkhardt Seifert; Fabrice Stehlin; Maurice Redondo; Peter T Bauer; Richard Kobza; Therese J Resink; Dragana Radovanovic
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

Review 6.  Cardiomyopathies and Adrenal Diseases.

Authors:  Luigi Petramala; Antonio Concistrè; Federica Olmati; Vincenza Saracino; Cristina Chimenti; Andrea Frustaci; Matteo A Russo; Claudio Letizia
Journal:  Int J Mol Sci       Date:  2020-07-17       Impact factor: 5.923

Review 7.  The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism.

Authors:  Gian Paolo Rossi; Valeria Bisogni; Alessandra Violet Bacca; Anna Belfiore; Maurizio Cesari; Antonio Concistrè; Rita Del Pinto; Bruno Fabris; Francesco Fallo; Cristiano Fava; Claudio Ferri; Gilberta Giacchetti; Guido Grassi; Claudio Letizia; Mauro Maccario; Francesca Mallamaci; Giuseppe Maiolino; Dario Manfellotto; Pietro Minuz; Silvia Monticone; Alberto Morganti; Maria Lorenza Muiesan; Paolo Mulatero; Aurelio Negro; Gianfranco Parati; Martino F Pengo; Luigi Petramala; Francesca Pizzolo; Damiano Rizzoni; Giacomo Rossitto; Franco Veglio; Teresa Maria Seccia
Journal:  Int J Cardiol Hypertens       Date:  2020-04-15

8.  Prevalence and prognostic value of cirrhotic cardiomyopathy as defined according to the proposed new classification.

Authors:  Maurizio Cesari; Anna Chiara Frigo; Salvatore Piano; Paolo Angeli
Journal:  Clin Exp Hepatol       Date:  2021-08-23

9.  CMR-Verified Myocardial Fibrosis Is Associated With Subclinical Diastolic Dysfunction in Primary Aldosteronism Patients.

Authors:  Fangli Zhou; Tao Wu; Wei Wang; Wei Cheng; Shuang Wan; Haoming Tian; Tao Chen; Jiayu Sun; Yan Ren
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-14       Impact factor: 5.555

10.  Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score-Matching Follow-Up Study With Tissue Doppler Imaging.

Authors:  Yi-Yao Chang; Che-Wei Liao; Cheng-Hsuan Tsai; Ching-Way Chen; Chien-Ting Pan; Zheng-Wei Chen; Ya-Li Chen; Lung-Chun Lin; Yi-Ru Chang; Vin-Cent Wu; Kwan-Dun Wu; Chi-Sheng Hung; Yen-Hung Lin
Journal:  J Am Heart Assoc       Date:  2019-11-13       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.